55 related articles for article (PubMed ID: 3030069)
1. Study of platelet alpha 2-adrenoceptors in Parkinson's disease.
Montastruc JL; Villeneuve A; Berlan M; Lafontan M; Caranobe C; Boneu B; Rascol A
Adv Neurol; 1987; 45():253-8. PubMed ID: 3030069
[No Abstract] [Full Text] [Related]
2. Platelet alpha 2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatment.
Villeneuve A; Berlan M; Lafontan M; Caranobe C; Boneu B; Rascol A; Montastruc JL
Eur J Clin Invest; 1985 Dec; 15(6):403-7. PubMed ID: 3007161
[TBL] [Abstract][Full Text] [Related]
3. Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients.
Brodde OE; Daul A; O'Hara N; Bock KD
J Hypertens Suppl; 1984 Dec; 2(3):S111-4. PubMed ID: 6100731
[TBL] [Abstract][Full Text] [Related]
4. Alteration of platelet alpha 2-adrenoceptors in human hypertension.
Continsouza-Blanc D; Elghozi JL; Dausse JP
J Hypertens Suppl; 1984 Dec; 2(3):S155-7. PubMed ID: 6100735
[TBL] [Abstract][Full Text] [Related]
5. Endurance training and human alpha 2-adrenergic receptors on platelets.
Lockette W; McCurdy R; Smith S; Carretero O
Med Sci Sports Exerc; 1987 Feb; 19(1):7-10. PubMed ID: 3029532
[TBL] [Abstract][Full Text] [Related]
6. Alpha-adrenergic receptor function in schizophrenia, affective disorders and some neurological diseases.
Kafka MS; van Kammen DP; Kleinman JE; Nurnberger JI; Siever LJ; Uhde TW; Polinsky RJ
Commun Psychopharmacol; 1980; 4(6):477-86. PubMed ID: 6271498
[No Abstract] [Full Text] [Related]
7. alpha 2-Adrenergic receptor binding in human platelets: alterations during the menstrual cycle.
Jones SB; Bylund DB; Rieser CA; Shekim WO; Byer JA; Carr GW
Clin Pharmacol Ther; 1983 Jul; 34(1):90-6. PubMed ID: 6305547
[TBL] [Abstract][Full Text] [Related]
8. Apparent "down-regulation" of human platelet alpha 2-adrenergic receptors is due to retained agonist.
Karliner JS; Motulsky HJ; Insel PA
Mol Pharmacol; 1982 Jan; 21(1):36-43. PubMed ID: 6127620
[No Abstract] [Full Text] [Related]
9. Platelet alpha 2-adrenoceptors and diurnal changes of platelet aggregability in hypertensive patients.
Mores N; Martire M; Pistritto G; Volpe AR; Menini E; Folli G; Cardillo C
J Hypertens; 1994 Aug; 12(8):939-45. PubMed ID: 7814853
[TBL] [Abstract][Full Text] [Related]
10. Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine.
Motulsky HJ; Shattil SJ; Insel PA
Biochem Biophys Res Commun; 1980 Dec; 97(4):1562-70. PubMed ID: 6260094
[No Abstract] [Full Text] [Related]
11. Solubilization of human platelet alpha-adrenergic receptors: evidence for agonist-promoted receptor-effector association.
Limbird LE; MacMillan ST; Smith SK
Adv Cyclic Nucleotide Res; 1981; 14():189-98. PubMed ID: 6116384
[No Abstract] [Full Text] [Related]
12. Different sedimentation properties of agonist- and antagonist-labelled platelet alpha 2 adrenergic receptors.
Michel T; Hoffman BB; Lefkowitz RJ; Caron MG
Biochem Biophys Res Commun; 1981 Jun; 100(3):1131-6. PubMed ID: 6268079
[No Abstract] [Full Text] [Related]
13. Alpha-adrenergic stimulation of phosphatidylinositol synthesis in human platelets as an alpha-2 effect secondary to platelet aggregation.
Wallace MA; Agarwal KC; Garcia-Sainz JA; Fain JN
J Cell Biochem; 1982; 18(2):213-20. PubMed ID: 6121823
[TBL] [Abstract][Full Text] [Related]
14. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
Macfarlane DE; Stump DC
Mol Pharmacol; 1982 Nov; 22(3):574-9. PubMed ID: 6296652
[TBL] [Abstract][Full Text] [Related]
15. Tetrahydroisoquinolines and beta-carbolines: specific binding to human platelet alpha 2-receptors in vitro.
Given MB; Longenecker GL
Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):349-52. PubMed ID: 6314454
[TBL] [Abstract][Full Text] [Related]
16. Effect of clomipramine treatment on dog platelet alpha 2-adrenergic receptivity.
Villeneuve A; Berlan M; Paris H; Tran MA; Lafontan M; Montastruc JL; Montastruc P
J Pharmacol; 1986; 17(4):644-50. PubMed ID: 3031380
[TBL] [Abstract][Full Text] [Related]
17. Effect of nifedipine and verapamil on alpha-receptor-activation in patients with essential hypertension.
Fritschka E; Distler A; Lenz T; Kribben A; Schudrowitsch L; Philipp T
J Hypertens Suppl; 1984 Dec; 2(3):S535-8. PubMed ID: 6100753
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis of atherosclerosis and blood platelets: problems of platelet activation in arteriosclerosis--with special reference to platelet membrane receptors].
Satoh Y; Tanaka Y; Satoh H
Nihon Rinsho; 1988 Mar; 46(3):582-9. PubMed ID: 2841513
[No Abstract] [Full Text] [Related]
19. Increased affinity and preference of halogenated derivatives of BE 2254 for alpha 1-adrenoceptors demonstrated by functional and binding experiments.
Schlicker E; Brodde OE; Göthert M; Schaperdoth M
J Cardiovasc Pharmacol; 1984; 6(6):1238-44. PubMed ID: 6084785
[TBL] [Abstract][Full Text] [Related]
20. Platelet alpha 2-adrenoceptor binding does not predict brain alpha 2-adrenoceptor function.
Nutt DJ
Br J Clin Pharmacol; 1987 Jul; 24(1):122-3. PubMed ID: 3040058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
